How Much Does Ketamine Therapy Cost? A Complete 2025 Pricing Guide

The Reality of Ketamine Therapy Costs

One of the first questions people ask when considering ketamine therapy is: how much will this cost? The answer depends on several interrelated factors, including the administration method, clinical setting, geographic location, treatment frequency, and whether any portion is covered by insurance.

Ketamine therapy spans a wide cost spectrum. At the most affordable end, compounded oral or sublingual formulations prescribed through telehealth services can cost as little as $100 to $350 per month. At the higher end, in-clinic IV infusions may run $400 to $800 per session, with the initial treatment series alone totaling several thousand dollars. Understanding these costs in detail is essential for planning a sustainable treatment approach.

This guide breaks down the full cost picture across every major treatment method, addresses insurance considerations, and identifies strategies for managing expenses.

IV Ketamine Infusion Costs

Intravenous ketamine infusion is the most extensively studied method for psychiatric applications and is offered by specialized ketamine clinics throughout the United States. It is almost always an out-of-pocket expense for psychiatric indications because IV ketamine for depression and anxiety is an off-label use.

Per-Session Pricing

Individual IV infusion sessions typically cost between $400 and $800. This price generally includes the pre-treatment assessment and vital signs check, the ketamine medication itself, IV supplies and infusion pump use, clinical monitoring throughout the 40-minute infusion, a post-infusion recovery period of 30 to 60 minutes, and final vital signs assessment before discharge.

Pricing varies significantly by geography. Clinics in major metropolitan areas such as New York, Los Angeles, San Francisco, and Chicago tend to charge at the higher end of the range, while clinics in smaller cities and suburban areas often offer lower rates. Competition among clinics in a given market also influences pricing.

Initial Treatment Series

The standard initial protocol consists of six infusions administered over two to three weeks. At typical per-session rates:

• Low estimate: 6 sessions at $400 = $2,400
• Mid estimate: 6 sessions at $550 = $3,300
• High estimate: 6 sessions at $800 = $4,800

Some clinics offer package pricing for the initial series that reduces the effective per-session cost by 10% to 20%. It is worth asking about package deals before committing.

Maintenance Costs

After the initial series, most patients require ongoing maintenance infusions to sustain the therapeutic benefits. Maintenance frequency varies by individual, typically ranging from every two weeks to every six weeks.

Annual maintenance estimates based on different schedules:

Including the initial series, first-year costs commonly range from $6,000 to $15,000 depending on maintenance frequency.

Spravato (Intranasal Esketamine) Costs

Spravato is manufactured by Janssen Pharmaceuticals and is the only FDA-approved ketamine-based treatment for depression. Its FDA-approved status fundamentally changes the insurance equation compared to off-label ketamine.

List Price

The manufacturer's list price for Spravato is approximately $600 to $900 per session, depending on the dose (56 mg or 84 mg). In addition to the medication cost, patients may be charged a facility fee for the required two-hour post-dose monitoring period. Facility fees range from $50 to $300 per session depending on the clinical setting.

With Insurance Coverage

For patients whose insurance covers Spravato, the out-of-pocket cost is often dramatically reduced:

• Copay with coverage: Commonly $0 to $200 per session
• After deductible: Costs depend on whether the annual deductible has been met
• Janssen savings program: The manufacturer offers a patient savings card that can reduce costs for commercially insured patients to as low as $10 per session

Estimated annual cost with insurance: $2,000 to $6,000 depending on copay structure, deductible, and session frequency.

Without Insurance Coverage

For patients without insurance coverage for Spravato, costs are substantially higher:

• Per session: $600-$900 (medication) + $50-$300 (facility fee)
• Annual estimate: $15,000-$30,000+

This makes uninsured Spravato treatment the most expensive option among all ketamine methods.

Getting Insurance Approval

Most insurance plans require documentation that the patient has treatment-resistant depression (typically defined as failure to respond to at least two adequate antidepressant trials) before approving Spravato. The prior authorization process involves the prescribing provider submitting clinical documentation, the insurance company reviewing the medical necessity, possible peer-to-peer review if initially denied, and an appeals process if the initial request is rejected.

The approval timeline can range from a few days to several weeks. Persistence is often required, and some providers employ staff specifically to manage prior authorizations. For a deeper dive into the insurance landscape, see our article on insurance coverage trends in 2025.

Oral and Sublingual Ketamine Costs

Compounded oral and sublingual formulations represent the most affordable entry point for ketamine therapy. These are typically prescribed by psychiatrists or other qualified providers through in-person visits or telehealth platforms.

Telehealth Program Pricing

Several telehealth companies offer comprehensive at-home ketamine treatment programs. Typical pricing structures include:

Monthly subscription models:

• Basic programs: $150-$250/month (includes medication, provider consultations, and monitoring)
• Premium programs: $250-$400/month (may include more frequent check-ins, integration coaching, or psychotherapy support)

Per-session pricing:

• Some providers charge per consultation plus separate medication costs
• Provider consultation: $100-$250 per visit
• Compounded medication: $50-$150 per month for the lozenges or tablets themselves

In-Person Prescribing

Patients who receive oral or sublingual ketamine prescriptions from a local psychiatrist or pain management specialist may encounter a different cost structure:

• Initial evaluation: $200-$500
• Follow-up visits: $100-$300 each (frequency varies)
• Compounded medication: $50-$200 per month from a specialty pharmacy
• Annual estimate: $1,500-$5,000 depending on visit frequency and pharmacy costs

Why It Is Cheaper

Several factors contribute to the lower cost of oral and sublingual ketamine. There are no clinic facility fees for in-office treatment sessions. The medication itself is relatively inexpensive to compound. Telehealth delivery reduces overhead compared to operating a clinical infusion suite. And the visit frequency is typically lower than for IV infusions once a stable dose is established.

Intramuscular (IM) Injection Costs

Intramuscular ketamine injection falls between IV infusion and oral formulations in both cost and clinical characteristics.

• Per session: $250-$600
• Setting: Administered in a clinical setting, though some providers train patients for self-administration under supervision
• Annual estimate: $3,000-$9,000 depending on frequency

IM injection is less commonly offered than IV infusion or oral formulations, so availability may be more limited.

Hidden and Additional Costs

Beyond the direct treatment costs, patients should account for several additional expenses.

Transportation

In-clinic treatments (IV, Spravato, and IM) require a companion to drive the patient home. For patients without a readily available driver, rideshare or taxi costs can add $20 to $60 per round trip, or $240 to $720 annually for monthly treatments.

Time Away From Work

Each in-clinic session requires approximately two to three hours, not including travel time. For patients without flexible work schedules, lost wages or the use of paid time off represents a real cost.

Complementary Therapies

Many providers recommend combining ketamine with psychotherapy, particularly cognitive behavioral therapy or ketamine-assisted psychotherapy (KAP). Additional therapy sessions typically cost $100 to $250 per session and may or may not be covered by insurance separately.

Lab Work and Medical Clearance

Some providers require baseline lab work (blood pressure monitoring, liver function tests, cardiac evaluation) before initiating treatment and periodically throughout therapy. These costs may range from $50 to $500 depending on the tests ordered and insurance coverage for diagnostic services.

Insurance Coverage: The Current Landscape

What Insurance Typically Covers

Spravato (esketamine): Most commercial insurance plans and Medicare cover Spravato for FDA-approved indications (treatment-resistant depression and major depressive disorder with suicidal ideation) after prior authorization. Medicaid coverage varies by state.

Off-label IV ketamine: The vast majority of insurance plans do not cover IV ketamine infusions for psychiatric conditions. Some rare exceptions exist, and coverage is more likely for pain-related indications where the clinical evidence is more established.

Compounded oral/sublingual ketamine: Generally not covered by insurance. The compounding pharmacy costs and telehealth consultation fees are almost always out-of-pocket.

Health Savings Accounts and Flexible Spending Accounts

Ketamine therapy expenses, including off-label uses, are generally eligible for payment through HSA (Health Savings Account) and FSA (Flexible Spending Account) funds, as they constitute medical expenses prescribed by a licensed healthcare provider. Patients should verify eligibility with their specific HSA or FSA administrator.

Strategies for Reducing Costs

Several approaches can help manage ketamine therapy expenses:

• Package pricing — Ask IV clinics about discounted rates for purchasing a series of sessions in advance
• Transitioning methods — Starting with IV infusion for the initial treatment response and then transitioning to less expensive oral maintenance is a common cost-optimization strategy
• Spravato savings programs — Janssen's patient savings card can significantly reduce out-of-pocket costs for commercially insured patients
• Telehealth providers — Competition among at-home ketamine companies has driven prices down in recent years; comparison shopping is worthwhile
• Tax deductions — Ketamine therapy costs may be deductible as medical expenses on federal tax returns if total medical expenses exceed 7.5% of adjusted gross income

Is Ketamine Therapy Worth the Cost?

The value proposition of ketamine therapy depends on individual circumstances, but several factors weigh in its favor for appropriate candidates.

For patients with treatment-resistant depression who have already tried multiple medications without success, the cost of continued suffering — lost productivity, damaged relationships, reduced quality of life, and the ongoing expense of ineffective treatments — often exceeds the cost of ketamine therapy.

Studies have demonstrated that ketamine therapy can reduce emergency department visits and psychiatric hospitalizations among patients with severe depression and suicidal ideation, yielding healthcare cost savings that partially offset treatment expenses.

That said, ketamine is not a cure. It is a treatment that typically requires ongoing maintenance. Patients should approach the financial commitment with a realistic understanding that costs will be recurring rather than one-time. For guidance on selecting a provider, see how to find a qualified ketamine provider.

Cost Comparison Summary

Important: The costs outlined in this guide are estimates based on publicly available information and commonly reported price ranges as of 2025. Actual costs vary by provider, location, and individual treatment plans. Always confirm pricing directly with your chosen provider before beginning treatment.

References

• NIMH: Mental Health Information — National Institute of Mental Health resources on mental health conditions and treatment options
• FDA: Spravato (Esketamine) Prescribing Information — Official FDA labeling including dosing information relevant to cost calculations
• CMS: Medicare Coverage — Centers for Medicare and Medicaid Services information on coverage policies relevant to ketamine-based treatments
• Mayo Clinic: Treatment-Resistant Depression — Overview of treatment-resistant depression and the clinical rationale for alternative therapies
• StatPearls: Ketamine — Clinical reference on ketamine pharmacology, including information on administration routes that influence cost structures
• IRS Publication 502: Medical and Dental Expenses — IRS guidelines on medical expense deductions relevant to out-of-pocket ketamine therapy costs